MARKET

BIIB

BIIB

Biogen Inc
NASDAQ
193.81
-7.37
-3.66%
Pre Market: 193.99 +0.18 +0.09% 08:32 02/10 EST
OPEN
199.83
PREV CLOSE
201.18
HIGH
201.00
LOW
191.88
VOLUME
284
TURNOVER
176.53M
52 WEEK HIGH
202.41
52 WEEK LOW
110.04
MARKET CAP
28.43B
P/E (TTM)
22.05
1D
5D
1M
3M
1Y
5Y
1D
Biogen Refocuses On High-Need Neurology As New Drugs Reach Inflection Point
Simply Wall St · 10h ago
Biogen Price Target Raised to $230.00/Share From $220.00 by Canaccord Genuity
Dow Jones · 18h ago
Biogen Is Maintained at Buy by Canaccord Genuity
Dow Jones · 18h ago
Canaccord Genuity Maintains Buy on Biogen, Raises Price Target to $230
Benzinga · 18h ago
Biogen Is Maintained at Market Perform by BMO Capital
Dow Jones · 19h ago
BMO Capital Maintains Market Perform on Biogen, Raises Price Target to $196
Benzinga · 19h ago
Biogen Is Maintained at Buy by TD Cowen
Dow Jones · 21h ago
TD Cowen Maintains Buy on Biogen, Raises Price Target to $215
Benzinga · 21h ago
More
About BIIB
Biogen Inc. is a global biopharmaceutical company. The Company is focused on discovering, developing, and delivering advanced therapies for people living with serious and complex diseases worldwide. It operates a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). It is focused on advancing its pipeline in neurology, specialized immunology, and rare diseases. Its marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; SKYCLARYS for the treatment of Friedreich's Ataxia; QALSODY for the treatment of ALS, and FUMADERM for the treatment of severe plaque psoriasis. It also collaborations with Eisai on the commercialization of LEQEMBI for the treatment of Alzheimer's disease and Sage on the commercialization of ZURZUVAE for the treatment of Postpartum Depression (PPD).

Webull offers Biogen Inc stock information, including NASDAQ: BIIB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIIB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIIB stock methods without spending real money on the virtual paper trading platform.